Echo IQ Limited (ASX:EIQ)

Market Cap	138.72M
Revenue (ttm)	129.91K
Net Income (ttm)	-8.87M
Shares Out	645.19M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,225,204
Average Volume	718,301
Open	0.2150
Previous Close	0.2150
Day's Range	0.1950 - 0.2170
52-Week Range	0.1400 - 0.3700
Beta	0.02
RSI	28.94
Earnings Date	Aug 29, 2025

About SpringWorks Therapeutics

Echo IQ Limited provides artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. It operates through Houston We Have Software and Echo IQ segments. The company offers EchoSolv, an AI software for identification of aortic stenosis heart condition to physicians and healthcare facilities. It also provides software products and services for the defence and other sectors. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited i...

• Industry: Software - Application
• Sector: Technology
• CEO: Dustin Haines
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EIQ

Financial Performance

In 2024, Echo IQ's revenue was 44,500, a decrease of -58.54% compared to the previous year's 107,332. Losses were -5.41 million, -31.14% less than in 2023.